Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size is projected to reach US$ 6098.5 million by 2027, from US$ 2378.2 million in 2020, at a CAGR of 14.4% during 2021-2027.
Global 23-Valent Pneumococcal Polysaccharide Vaccine Scope and Segment
The global 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global 23-Valent Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Single Dose Vial
Pre-filled Syringe
By the end users/application, this report covers the following segments
For Children (2-10)
For Person (10-64)
For The Old (Above or equal to 65)
Competitive Landscape:
The report provides a list of all the key players in the 23-Valent Pneumococcal Polysaccharide Vaccine market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The 23-Valent Pneumococcal Polysaccharide Vaccine key manufacturers in this market include:
MSD
Sanofipasteur
CDIBP

TABLE OF CONTENT

1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Type
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Overview by Type (2016-2027)
1.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2030)
1.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2030)
1.4.4 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2030)

2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Company
2.1 Global Top Players by 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2016-2030)
2.2 Global Top Players by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2030)
2.3 Global Top Players 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2030)
2.4 Global Top Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
2.7 Date of Key Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
2.8 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion

3 23-Valent Pneumococcal Polysaccharide Vaccine Status and Outlook by Region
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Region
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2016-2030)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2016-2030)
3.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Region
3.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2022-2027)
3.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2022-2027)
3.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Application
4.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Application
4.1.1 For Children (2-10)
4.1.2 For Person (10-64)
4.1.3 For The Old (Above or equal to 65)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Overview by Application (2016-2027)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2030)
4.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2030)
4.3.4 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2030)

5 North America 23-Valent Pneumococcal Polysaccharide Vaccine by Country
5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Country
5.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2016-2030)
5.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2016-2030)
5.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Country
5.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2022-2027)
5.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2022-2027)

6 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
6.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Country
6.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2016-2030)
6.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2016-2030)
6.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Country
6.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2022-2027)
6.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2022-2027)

7 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine by Region
7.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2016-2030)
7.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2022-2027)

8 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Country
8.1.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2016-2030)
8.1.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2016-2030)
8.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Country
8.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2022-2027)
8.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2022-2027)

9 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
9.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2016-2030)
9.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in 23-Valent Pneumococcal Polysaccharide Vaccine Business
10.1 MSD
10.1.1 MSD Corporation Information
10.1.2 MSD Introduction and Business Overview
10.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
10.1.5 MSD Recent Development
10.2 Sanofipasteur
10.2.1 Sanofipasteur Corporation Information
10.2.2 Sanofipasteur Introduction and Business Overview
10.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
10.2.5 Sanofipasteur Recent Development
10.3 CDIBP
10.3.1 CDIBP Corporation Information
10.3.2 CDIBP Introduction and Business Overview
10.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
10.3.5 CDIBP Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
11.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample